TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 254 filers reported holding TG THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,207,893 | +36.0% | 180,320 | +16.3% | 0.43% | +48.8% |
Q1 2024 | $2,358,143 | -32.8% | 155,039 | -24.5% | 0.29% | -41.5% |
Q4 2023 | $3,506,814 | +100.4% | 205,317 | -1.9% | 0.49% | +53.9% |
Q3 2023 | $1,749,907 | -68.1% | 209,319 | -5.1% | 0.32% | -66.2% |
Q2 2023 | $5,480,549 | +32.2% | 220,634 | -20.0% | 0.95% | +5.3% |
Q1 2023 | $4,145,641 | – | 275,641 | – | 0.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 10,451,241 | $157,186,665 | 42.99% |
M28 Capital Management LP | 339,500 | $5,106,080 | 5.77% |
Ghost Tree Capital, LLC | 1,100,000 | $16,544,000 | 4.89% |
Soleus Capital Management, L.P. | 750,300 | $11,284,512 | 1.17% |
Parkman Healthcare Partners LLC | 275,641 | $4,145,641 | 0.90% |
683 Capital Management, LLC | 775,000 | $11,656,000 | 0.87% |
Leucadia National | 5,100,110 | $76,705,654 | 0.62% |
Pier Capital, LLC | 233,472 | $3,511,419 | 0.53% |
Harvest Investment Services, LLC | 40,729 | $612,564 | 0.47% |
Artal Group S.A. | 511,389 | $7,691 | 0.46% |